GMEB-SASS: A Gene-Modified Skin Substitute for RDEB Treatment

Clinical trial NCT07193134 · RECRUITING

Trial details

NCT number: NCT07193134
Sponsor: CHU de Quebec-Universite Laval
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

RDEB Recessive Dystrophic Epidermolysis Bullosa Epidermolysis Bullosa Dystrophica, Recessive

Start date: 2026-01-07
Primary completion: 2030-12-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.